Category Archives: U.S. Policy and Funding

U.S. voices strong support for health security in Geneva while curtailing support in Washington

By on .

Infectious Diseases Society of America Senior Global Health Policy Specialist Rabita Aziz sent this dispatch from the 71st World Health Assembly in Geneva, where she will deliver remarks on behalf of IDSA, which produces this blog, and other organizations, this week. GENEVA – The U.S. will contribute an additional $7 million on top of a […]

White House rescission proposal, House resolution highlight disconnect between federal priorities, global realities

By on .

On Tuesday, as the World Health Organization announced that Ebola had broken out in the Democratic Republic of Congo for the second time in a year, and the ninth time since the discovery of the disease there in the late 1970s, the White House released one more proposal to to cut funding for global and […]

Analysis: Global health research and development spending comes home, in disease solutions and dollars

By on .

With budget proposals titled “America First: A Budget Blueprint to Make America Great Again“ for fiscal year 2018, and “An American Budget” for 2019, the premise of White House budget plans that would slash funding for global health research and development to levels not seen since the start of this century seemed predicated on the […]

Yellow fever vaccine entry requirements leave big gaps

By on .

Fewer than a quarter of airplane passengers traveling to countries where yellow fever is endemic  were required to show proof of vaccination against the disease upon arrival, when they were traveling from countries where the disease is not transmitted locally, according to a report released this week by the World Health Organization. The finding, the […]

New Secretary of State a blank slate on global health

By on .

Global infectious diseases responses not addressed Mike Pompeo’s hearing, testimony for Secretary of State confirmation President Trump applauded the confirmation of Mike Pompeo as the new Secretary of State Thursday, saying “He will always put the interests of America first.” In the view of many, including at least his three most recent predecessors, that would […]

In taking the One Health approach, is Senegal showing the way?

By on .

The following is a guest post by Scott Moreland, PhD of MEASURE Evaluation Recent experience with the threat of Ebola Virus Disease in West Africa, specifically Guinea, has rung a few bells in neighboring Senegal. Approximately 75 percent of new infectious diseases that threaten people have been shown to be zoonotic—that is, originating from animals […]

Modeling tool tells when pairing responses to “big three” and neglected diseases is a win-win

By on .

The idea of pairing responses to diseases found in the global south that are so neglected that they are classified by that word with the better-funded, but still constrained responses to the so-called “Big Three” of HIV, tuberculosis and malaria, was not new. Neither was the hope that those combined efforts could streamline infectious disease control […]

Infection is unwanted souvenir from medical tourists’ trips

By on .

Three patients with post-operative infections reported by New York Health officials in May 2017 to the U.S. Centers for Disease Control and Prevention sparked an investigation that revealed 35 more patients from nine states who had traveled to the Dominican Republic for cosmetic procedures and returned with nontuberculosis myobacteria. The investigation led to the temporary […]

Spending bill boosts NIH, USAID TB, lifts Fogarty, flatlines PEPFAR, Global Fund

By on .

The spending bill for 2018 passed in the House Thursday, and the Senate early today has delivered a robust rejection of the President’s proposals to slash science spending while massively cutting funds for global infectious disease responses, with a combination of level funding and a few notable raises. They include with a $3 billion boost for […]

CDC tells Brazil travelers get a yellow fever vaccination — and it might be hard to find

By on .

Plan ahead . . .  FDA-approved shot is unavailable, and with limited availability of alternative vaccine, getting inoculated may be a journey in itself . . . Following 10 cases of yellow fever linked to travel in Brazil that led to four deaths this year so far, the U.S. Centers for Disease Control and Prevention has […]